Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Memphasys.
RELATED STOCKHEAD STORIES
News
ASX Lunch Wrap: Curve ball thrown as new bank levy bites; Alderan jumps on US copper hit
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Alive and Kicking: Lumos Diagnostics attracts ‘Twiggy’ Forrest as cornerstone holder in $10m raise
News
Market Highlights: ASX to fall sharply after Wall Street plunges; Nvidia hammered 9.5pc
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Alcidion soars as it helps bring UK patient records into digital age
News
Closing Bell: ASX rides high as gold, silver, copper, and iron ore surge; Nuix jumps 25pc
Health & Biotech
ASX Health Stocks: Memphasys’ Felix triumphs over traditional sperm-prepping methods for IVF
News
Closing Bell: Strap on the horns ‘cos it’s five straight on the ASX with Materials a gimme when China talks stimmy
Health & Biotech
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
News
Top 10 at 10: Data stock on the rise as Domino’s gets burnt, cattle inseminator shoots blanks
News
In Case You Missed It: Lithium, chocolate and an IVF tech distribution deal
News
Closing Bell: ASX surges late as weak China PMIs smell a lot like pre-stimmy
Health & Biotech
ASX Health Stocks: Memphasys reports 10 new live births in India using its Felix System
Health & Biotech
ASX Health Stocks: Firebrick achieves primary endpoint in Phase 2; Memphasys surges 20pc on Japan deal
News
